1. Risk for deficient fluid volume related to nausea and vomiting and limited oral intake
2. Patient remains free from nausea and vomiting with use of pharmacologic and nonpharmacologic therapies.
3. Patient regains mobility status and/or remains with stable mobility during drug therapy.
Already registered? Login
Not Account? Sign up
Enter your email address to reset your password
Back to Login? Click here